Patrick DalyHematology | November 16, 2023
Dr. Masarova spoke with HemeToday on findings from a treatment comparison of pacritinib and momelotinib in myelofibrosis.
View More
Patrick DalyAnemia | November 14, 2023
Testosterone replacement therapy improved anemia remission and new anemia prevention versus placebo in men with hypogonadism.
Rob DillardAHA 2023 | November 11, 2023
A study indicates that blood transfusions for anemic patients hospitalized with heart attack may improve patient outcomes.
Patrick DalyAnemia | November 6, 2023
Fostamatinib improved hemoglobin response in warm antibody autoimmune hemolytic anemia versus placebo in the FORWARD trial.
Patrick DalyAnemia | October 30, 2023
Plasma thrombopoietin was significantly higher in aplastic anemia and myelodysplastic syndromes compared with control values.
Patrick DalyAnemia | October 23, 2023
HSCT from a haploidentical donor and PTCy improved neutrophil and platelet engraftment compared with UCBT in aplastic anemia.
Rob DillardHematology | October 3, 2023
Take a look at these important studies relevant to anemia, venous thromboembolism, sickle cell disease, and PNH.
Patrick DalyAnemia | September 25, 2023
Anemia appeared to increase risk of dementia and cognitive decline, and concurrent high CRP levels may further increase risk.
Cailin ConnerAnemia | August 16, 2023
Anemia patients with nonvalvular atrial fibrillation have a higher risk of dying, a study finds.
Cailin ConnerAnemia | August 7, 2023
Preoperative anemia increases the risk of postoperative complications by over 30%.
Patrick DalyHeart Failure | July 28, 2023
Sacubitril/valsartan therapy improved outcomes compared with enalapril in heart failure with preserved ejection fraction.
Rob DillardASCO 2023 | June 3, 2023
Zilurgisertib appears safe and well tolerated in patients who have anemia due to myelofibrosis.
Rob DillardASCO 2023 | May 31, 2023
The safety and efficacy of luspatercept is favorable for treating anemia in patients with myelofibrosis.
The Fellow on CallThe Fellow on Call | March 16, 2023
Your hosts continue their journey through the realm of cytopenias.
DocWire News EditorsASH Annual Meeting and Exposition 2021 | December 11, 2021
Based on analysis of data from the ACTIVATE and ACTIVATE-T studies and their associated long-term extension (LTE) ...
Rob DillardMDS | November 2, 2021
Anemia is the predominant cytopenia in myelodysplastic syndromes (MDS), and treatment options are limited. Roxadustat, ...
DocWire News EditorsAAOS 2021 | September 1, 2021
Anemia is a common health condition that affects approximately one-quarter of the population and a significant portion ...
Rob DillardHematology | January 29, 2021
When physicians suspect a diagnosis of certain conditions, a referral to a hematologist is warranted.
Kerri FitzgeraldASH Annual Meeting 2020 | December 17, 2020
Alpha-globin mutations are common, and the number and type of mutated alleles will determine the severity of subsequent ...
Rebecca AraujoAnemia | November 4, 2020
A regimen of oral iron supplements alone was found to be comparable to oral iron plus vitamin C supplements in improving ...
Latest News

December 1, 2023